Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

August 18, 2022 01:02:07
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update
MitoAction Expert Series
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

Aug 18 2022 | 01:02:07

/

Show Notes

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Other Episodes

Episode

April 12, 2022 01:18:38
Episode Cover

Tummy Troubles

MITO Meeting: MONTHLY INTERNATIONAL TELECONFERENCE OUTREACH Join us this month with Dr. Alex Flores, Chief of Pediatric Gastroenterology and Nutrition, Floating Hospital for Children...

Listen

Episode

June 24, 2022 01:02:59
Episode Cover

Spectrum Needs, a New Comprehensive Nutritional Therapy for Autism, Functional Conditions and Mitochondrial Disease - 4/6/2018

Talking points include: -What does the medical literature say regarding the uses of nutritional therapies in the autism and related neurodevelopmental disorders? -What about...

Listen

Episode 0

December 04, 2020 01:01:13
Episode Cover

Mito Basics: Genetics, Testing and Financial - David Keane - 12/4/20

Join MitoAction and David Keane from GeneDX for our December Monthly Mito Expert Series presentation titled: Mito Genetic Basics: Disease, Testing and Financial.  About...

Listen